Phase I study to assess pharmacokinetics (PK), QT/QTc effect, and safety of amrubicin in patients (pts) with advanced solid tumors.
N. Chen
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
S. P. Chawla
Research Funding - Celgene
E. G. Chiorean
Research Funding - Celgene
W. L. Read
Research Funding - Celgene
M. Gorbaty
No relevant relationships to disclose
A. C. Mita
No relevant relationships to disclose
L. Yung
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
R. McNally
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
M. F. Renschler
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
S. Sharma
Research Funding - Celgene